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https://doi.org/10.1016/j.celrep.2020.107748SUMMARYImmunological homeostasis in T cells is maintained by a tightly regulated signaling and transcriptional
network. Full engagement of effector T cells occurs only when signaling exceeds a critical threshold that en-
ables induction of immune response genes carrying an epigenetic memory of prior activation. Here we inves-
tigate the underlying mechanisms causing the suppression of normal immune responses when T cells are
rendered anergic by tolerance induction. By performing an integrated analysis of signaling, epigenetic mod-
ifications, and gene expression, we demonstrate that immunological tolerance is established when both
signaling to and chromatin priming of immune response genes are weakened. In parallel, chromatin priming
of immune-repressive genes becomes boosted, rendering them sensitive to low levels of signaling below the
threshold needed to activate immune response genes. Our study reveals how repeated exposure to antigens
causes an altered epigenetic state leading to T cell anergy and tolerance, representing a basis for treating
auto-immune diseases.INTRODUCTION
The maintenance of immunological homeostasis requires T cell
responses to antigen (Ag) to be both tightly regulated and recep-
tive to negative feedback. The engagement of effector T cells is
dependent on the activation of multiple parallel signaling path-
ways, thereby ensuring appropriate immune responses. The
magnitude of the response to T cell receptor (TCR) signaling
can also be suppressed by inducing an anergic state in response
to: (1) repeated exposure to Ag, resulting in tolerance (Sabatos-
Peyton et al., 2010); (2) lack of co-receptor stimulation
(Schwartz, 2003); or (3) negative feedback from inhibitory recep-
tors, such as PD-1, CTLA4, LAG3, TIM3, and TIGIT, as seen in
tumor-infiltrating lymphocytes (TILs) and exhausted T cells fac-
ing chronic exposure to viral Ags (Anderson et al., 2016; Wherry
et al., 2007; Wherry and Kurachi, 2015). PD-1 reduces the
strength of TCR signaling below the threshold for many immune
response genes, but not for a subset of other inducible genes
that have a lower activation threshold (Shimizu et al., 2020).
However, the molecular basis for this phenomenon is unknown.
During a normal immune response, the co-activation of TCR
and CD28 signaling in effector T cells leads to the transcriptional
activation of hundreds of genes via inducible transcription fac-
tors (TFs), such as NFAT, AP-1, nuclear factor kB (NF-kB), andThis is an open access article undEGR1 (Yukawa et al., 2020; Figure 1A). These same TFs are
also strongly induced by the phorbol ester phorbol myristate ac-
etate (PMA) and the calcium ionophore A23187 (PI), which coop-
erate by activating diverging signaling pathways downstream of
phospholipase C (PLC) and protein kinase C (PKC) (Figure 1A;
Brignall et al., 2017). The pathways then re-converge in the nu-
cleus, where NFAT and AP-1 bind cooperatively to activate
gene expression (Chen et al., 1998; Johnson et al., 2004). Little
is known about how inhibitory receptors suppress these
signaling pathways and alter the T cell response. However,
numerous studies point to a role for the ubiquitin ligase Cbl-b,
which is activated by CTLA4 and PD-1 (Fujiwara et al., 2017; Li
et al., 2004, 2019). Cbl-b functions as a gatekeeper of T cell acti-
vation by antagonizing PLC, phosphatidylinositol 3-kinase
(PI3K), and PKC signaling (Fang and Liu, 2001; Heissmeyer
et al., 2004; Jeon et al., 2004). Furthermore, Cbl-b expression
is raised in T cells when anergy is induced by calcineurin
signaling to NFAT in the absence of PKC activation (Heissmeyer
et al., 2004) or by tolerizing signals (Jeon et al., 2004).
We previously showed that a single cycle of activation of TCR/
CD28 signaling pathways was sufficient to epigenetically repro-
gramchromatin domains encompassing immune response genes
in naive T cells, resulting in the stablemaintenance of altered chro-
matin states regulating gene accessibility and expressionCell Reports 31, 107748, June 9, 2020 ª 2020 The Author(s). 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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OPEN ACCESS(Bevington et al., 2016, 2017). When activated by Ag for the first
time, quiescent naive T cells undergo a slow transformation into
rapidly dividing T blast (TB) cells, duringwhich they remodel broad
chromatin domains carrying activating histone modifications and
encompassing inducible genes and their regulatory elements (Fig-
ure 1B). In response to TCR signaling, these regulatory elements
form open chromatin regions detectable as DNase I hypersensi-
tive sites (DHSs). Although inducible DHSs (iDHSs) are opened
up transiently by factors such as AP-1 and NFAT, and typically
function as inducible transcriptional enhancers or promoters,
3,000 of the DHSs formed during blast cell transformation are
stably maintained as primed DHSs (pDHSs) in TB and in memory
T cells without influencing steady-state transcription. Although
these pDHSs are initially opened in response to transient
activation of AP-1, they are then maintained by stable binding of
constitutively expressed TFs such as ETS-1 and RUNX1, which
introduce activating histone modifications into surrounding re-
gions, thereby maintaining an epigenetic memory of TCR activa-
tion (Bevington et al., 2016, 2017).
Several previous studies of anergy in the context of tolerance
have investigated the roles and regulation of production of Tr1
cells, which are a Foxp3ve subset of regulatory T cells, which
limit damage resulting from responses to infection and suppress
auto-immunity by secreting factors such as interleukin (IL)-10
(O’Garra and Vieira, 2007; Roncarolo et al., 2014; Trinchieri,
2007). Intra-nasal or subcutaneous administration of peptides
can induce an anergic IL-10-secreting Tr1-like population in vivo
(Burton et al., 2014; Gabrysova´ et al., 2009; Sundstedt et al.,
2003), and this treatment is effective in establishing tolerance
(Burton et al., 2014) and protecting against autoimmunity (Bur-
khart et al., 1999; Clemente-Casares et al., 2016; Gabrysova´
et al., 2009; O’Neill et al., 2006). Tr1-like cells can also be gener-
ated in vitro by culturing T cells in IL-27 (Pot et al., 2009). The Tr1
gene expression signature resembles that of both exhausted
TILs and exhausted T cells associated with chronic viral infec-
tions (Chihara et al., 2018). Tr1-like cells can also be induced
by repeated anti-CD3ε antibody exposure (Mayo et al., 2016)
or by nano-particles coated with peptide-bound major histo-
compatibility complex (MHC) class II (Clemente-Casares et al.,
2016). These studies show that TCR signaling is important in
generating tolerance (Wraith, 2016). However, although there is
a consensus surrounding the importance of Tr1-like cells in a va-
riety of immunological contexts, the molecular mechanisms that
lead to the generation of Tr1-like tolerant cells and their altered
response to Ag remain obscure.
To investigate the underlying basis of T cell tolerance, we per-
formed genome-wide profiling of gene-regulatory networks inFigure 1. Gene Expression Analyses Comparing Tolerized T Cells with
(A) Model of the activation of immune response genes by TCR and CD28 signa
signaling pathways downstream of PLC.
(B) The transcription factors activated by signaling (NFAT, AP-1) induce chromatin
enhancers. Enhancer activation initiates transcription of their target genes. When
(me) and acetylated (ac) chromatin by the retention of constitutively expressed t
(C) Schematic showing the dose escalation protocol used in tolerizing Tg4 mice
(D) Principle-component analysis of the RNA-seq datasets for the top 500 most v
three biological replicates.
(E and F) Normalized average RNA-seq counts for classical immune response (E)
from three biological replicates.T cells before and after induction of tolerance, and after reactiva-
tion of TCR signaling. For this, we employed a transgenic TCR
model (Tg4) (Liu et al., 1995) based on desensitization of mice
in response to escalating doses of a tolerizing peptide Ag (Fig-
ure 1C; Burton et al., 2014). Tg4 mouse T cells recognize the
Ac1-9 N-terminal peptide AcASQKRPSQR from myelin basic
protein (MBP), an encephalitogenic auto-Ag associated with
multiple sclerosis, and can be rendered tolerant by repeated
exposure to the higher affinity, MHC-binding MBP Ac1-9[4Y]
analog AcASQYRPSQR (4Y) (Burton et al., 2014). This approach
may form the basis of future therapies in auto-immune disease
because we have established that it alleviates symptoms of mul-
tiple sclerosis in patients (Chataway et al., 2018). To define
epigenetic mechanisms maintaining an anergic tolerant state in
Tg4 T cells, we identified DHSs on a genome-wide scale,
together with genome-wide RNA-seq. These integrated studies
demonstrated that the tolerized state is associated with two
distinct mechanisms. First, tolerized T cells specifically maintain
chromatin priming at a subset of pDHSs within archetypal T cell
tolerance signature genes, allowing them to be activated at a
signaling threshold below that of immune response genes. Sec-
ond, receptor signaling to AP-1 is suppressed, and tolerized
T cells fail to activate classic immune response genes in vivo in
response to TCR stimulation by peptide. Hence it is altered
epigenetic states that shift the balance between immune
response and immune repression following tolerization.
RESULTS
T Cell Tolerization Reprograms Inducible Gene
Expression Potential
In the Tg4 mouse model, tolerance induction correlates with the
induction of anergic CD4+ T cells with a Tr1 phenotype (Gabry-
sova´ et al., 2009). To address the molecular basis of this phe-
nomenon, we first undertook genome-wide analyses of changes
in gene expression (RNA sequencing [RNA-seq]) associated with
tolerance in both the steady state and following challenge with a
specific Ag. Tg4 transgenicmicewere tolerized by repeated sub-
cutaneous injection of the 4Y MBP peptide according to the
schedule outlined in Figure 1C. To examine TCR responses in to-
lerized T cells (T) and in non-tolerant predominantly naive T cells
(N) from control mice, we harvested cells 2 h after a final injection
with 80 mg 4Y peptide (TAg and NAg) or PBS vehicle (T0 and N0).
We also examined in vitro responses of T cells after a 2-h stimu-
lation with 20 ng/mL PMA and 2 mM calcium ionophore A23187
(TPI and NPI) so as to distinguish between mechanisms acting at
the level of TCR/CD28 signaling and transcriptional mechanismsNaive T Cells
ling to inducible TFs. Calcium ionophore A23187 and PMA act on the same
remodeling at immune response genes at both priming elements and inducible
signaling ceases, primed DHSs are stably maintained as regions of methylated
ranscription factors (ETS, RUNX).
by subcutaneous injections with MBP Ac1-9-specific TCR.
ariable genes for N0, T0, NAg, TAg, NPI, and TPI. RNA-seq data were taken from
and immune-modulatory genes (F). Error bars represent the standard deviation
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normalization of the data, we defined 17,179 loci where the
average RNA-seq value was at least 3 for at least one set of con-
ditions (Table S1). Principle-component analysis of the 500 most
variable genes using three biological replicates revealed sub-
stantial differences between naive and tolerized cells under all
conditions (PC1 versus PC3; Figure 1D) and robust responses
to Ag in both naive and tolerant cells (PC1 versus PC2; Fig-
ure S1A). Analysis of RNA-seq data for genes where values
changed by at least 2-fold after tolerization (Figure S1B), and
at least one value was above 50, revealed 475 loci higher and
107 loci lower in T0 than N0, (Table S2) and 568 loci higher and
381 loci lower in TAg than NAg (Table S3). Hierarchical clustering
was performed for 637 of these genes where at least one of the
T0:N0, TAg:NAg, TAg:T0, or NAg:N0 ratios showed at least a 10-fold
difference (Figure S1C). The combined analyses revealed im-
mune response genes, such as Il2, Il3, Tnf, Csf2, Ccl1, Cd40lg,
Nr4a3, and Nfkb1, which were less inducible in tolerized cells
treated with Ag (Figures 1E, S1C, and S1D), and anergy or toler-
ance-associated genes, which were more inducible, including
the inhibitory receptors Ctla4, Tigit, Lag3, Havcr2 (TIM3), and
Pdcd1 (PD1), the phosphatase Dusp6, the TFs Nfil3 and Maf,
and the immune-suppressive cytokines Il10 and Il21 (Figures
1F, S1C, and S1E). For many immune response genes, this
loss of responsiveness to TCR signaling could be bypassed by
direct stimulation with PI (Figures 1E and S1D), suggesting that
tolerance involves a membrane-proximal block in TCR signaling
to inducible TFs. In contrast, the weak response to TCR signaling
seen for many immuno-suppressive genes in naive cells could
not be boosted by PI. Similar responses were seen over an
extended time course of stimulation, demonstrating that it is
not just the kinetics but the magnitude of activation that varies
(Figures S1F and S1G). Some genes were also expressed at
higher levels in tolerized cells even prior to stimulation (Figures
1F, S1C, and S1E; Table S2). Many of the genes upregulated
in T0 had also been previously shown to be upregulated in Tr1-
like cells generated in vitrowith IL-27, suggesting similarities be-
tween these two model systems (Chihara et al., 2018; Table S4).
These include Maf, Il10, Il21, Havcr2, Lag3, Nfil3, and Prdm1.
These data suggest a potential model whereby tolerized T cells
exhibit both: (1) suppression of TCR/CD28 signaling to a level
below the threshold needed for activation of many immune
response genes; and (2) a heightened sensitivity of immuno-reg-Figure 2. DNase-Seq Analyses of Open Chromatin in Naive and Toleriz
(A and B) Average DHS signal at the 1,033 T0-specific DHSs (A) and at the 635 N
(C) DNase-seq sequence tag density plots showing all 26,227 peaks detected in r
count for T0 comparedwith N0. Alongside is the FC inmRNA level for the closest g
N0 (left), and TAg is compared with NAg (right). The locations of TF consensus bindin
LEF family proteins. Plotted alongside are published TF binding data from ChIP-
(Ciofani et al., 2012), and ectopic CA-RIT-NFAT1 in CD8 T cells (Martinez et al.,
(D and E) HOMER de novo identification of TF motifs enriched in the 1,033 T0-sp
(F) Average ChIP signal at the 1,033 T0-specific DHSs and 635 N0-specific DHSs
(G) UCSC Genome Browser tracks showing DNase-seq data from replicate sam
tolerant cells 3 weeks after the final dose of peptide (T0M), plus published DNase-
data are shown for the TFs TCF1, c-MAF, and CA-RIT-NFAT1 and the histone m
from one of three replicates are also shown for resting and in vivo peptide-stimu
(H and I) Bar graphs showing the percentage and proximity of genes that are prefe
of the 1,033 T0-specific DHSs.ulatory genes that still allows activation at reduced levels of TCR
signaling, consistent with the actions of inhibitory receptors such
as PD-1 (Shimizu et al., 2020). Significantly, TCR-inducible acti-
vation of Il2, Csf2, and Tnf is dependent on CD28 signaling (Yu-
kawa et al., 2020).
Modification of the Epigenetic Landscape in Tolerant
Cells
We next investigated whether the more efficient activation of a
subset of genes in tolerant cells was due to epigenetic reprog-
ramming at the level of chromatin modifications, as observed
in TB cells (Bevington et al., 2016). To this end, we globally iden-
tified DHSs in N0 and T0 cells using DNase sequencing (DNase-
seq). We ranked the DHSs based on the fold change of DNase-
seq signal between N0 and T0 for two independent replicates
(Figure S2A). We selected high-confidence subsets of DHSs
that were at least 2-fold different in both experiments. These an-
alyses identified 1,033 T0-specific DHSs (tDHSs) and 635 N0-
specific DHSs (Figures 2A, 2B, and S2A; Data S1). We also
used DESeq2 as an alternative method of statistical analysis to
screen for 2-fold changes and p < 0.05, and again identified
the vast majority of the 1,033 tDHSs defined above (84%;
Figure S2B).
We also investigated the stability of the tDHSs after a time in-
terval sufficient for peak effector T cell responses to have sub-
sided and for memory T cells to form (T0M, Figure 1C). We per-
formed DNase-seq on tolerized cells that had received the final
dose of Ag 3 weeks prior to harvest, and we still reproducibly de-
tected over half of the 1,033 tDHSs (Figure S2C) that maintained
an elevated average DHS signal (Figures 2A and 2C). These data
suggest that tolerization involves long-term maintenance of
epigenetic reprograming of a specific subset of DHSs in the
absence of sustained TCR signaling. To ascertain whether the
changes in chromatin structure had any impact on the nearby
genes, we measured the difference in mRNA expression for
the genes closest to the ranked DHSs for replicate 1 (Figure 2C).
We observed an increase in both steady-state (T0 comparedwith
N0) and inducible (TAg compared with NAg) gene expression in
parallel with the increase in DHS strength. This is consistent
with a role for epigenetic priming in the imprinting of a transcrip-
tional memory of TCR activation, thereby enabling both higher
steady-state expression in T0 and more efficient re-activation
in TAg compared with NAg.ed T Cells
0-enriched DHSs (B) in the replicate N0, T0, and T0M samples.
eplicate 1 of T0 and N0 ordered by increasing fold change (FC) of sequence tag
ene to the DHSs as ranked in the density plots. The FC is shown between T0 and
gmotifs within the same DHSs are shown alongside for AP-1, NFAT, MAF, and
seq analyses for TCF1 in thymocytes (Dose et al., 2014), c-MAF in Th17 cells
2015).
ecific DHSs (D) and the 635 N0-specific DHSs (E).
for TCF1, c-MAF, and CA-RIT-NFAT1.
ples of non-stimulated naive cells (N0), non-stimulated tolerant cells (T0), and
seq data for CD4 T blast (TB) cells (Bevington et al., 2016). Published ChIP-seq
odifications H3K27ac and H3K4me2 in TB cells. Representative RNA-seq data
lated naive and tolerant cells (0 and Ag).
rentially induced in T0 or N0 (H) and TAg or NAg (I), which are found within 100 kb
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OPEN ACCESSTogain insight into transcriptionalmechanismsunderlying toler-
ization, we used HOMER to perform de novo identification of TF
motifs in the different specific subsets of DHSs (Figures 2D, 2E,
and S2B). The tDHSs were more highly enriched in AP-1 and
NFAT motifs, whereas the pre-existing N0-specific DHSs con-
tained a higher proportion of LEF/TCF motifs. Both subsets were
enriched in RUNX, ETS, and CREB/ATF motifs. The distribution
of AP-1, NFAT,MAF, and LEF/TCFmotifs is depicted in Figure 2C,
where their direct correlation with the coordinates of the DHSs is
shown. Published chromatin immunoprecipitation sequencing
(ChIP-seq) data of TCF1 binding in thymocytes was consistent
with these in silicoobservations (Doseetal., 2014),withTCF1bind-
ing concentrated in both the N0-specific and shared peaks but
depleted in the tDHSs (Figures 2C and 2F). Conversely,MAFbind-
ing was more enriched in the tDHSs than the N0-specific DHSs
(Ciofani et al., 2012; Figures 2C and 2F). MAF has been shown to
be important in regulating Il10 expression (Xu et al., 2009) and is
implicated in repressing Il2 (Gabrysova´ et al., 2018).Maf is alsoup-
regulated inT0andTAgcells (Figure1F), andMAFcandimerizewith
other CREB/AP-1 family proteins to bind to AP-1 sites (Kataoka
et al., 1994), a motif that is enriched in the tDHSs (Figures 2C
and 2D). The enrichment of NFAT motifs in tDHSs may also be
functionally relevant because NFAT plays a role in T cell anergy
(Macia´n et al., 2002) and T cell exhaustion (Martinez et al., 2015).
Indeed, when we aligned our DNase-seq data with ChIP-seq
data generated using a constitutively active modified form of
NFAT1/NFATC2 (CA-RIT-NFAT), which is known to promote
exhaustion (Martinez et al., 2015), we observed that NFAT binding
was more strongly enriched in the tDHSs (Figures 2C and 2F).
Although it is unlikely/unknown whether NFAT is binding to these
sites in T0 cells before stimulation, the presence of the motif at
an open DHS should enable rapid binding when the cells are re-
exposed to Ag.
Examples of tDHSs with binding sites for MAF and NFAT were
found at the tolerance-associated Il10,Ctla4, Tigit, andNrp1 loci
(Figure 2G), where there are higher levels of either constitutive or
inducible mRNA expression in tolerized cells (Figures 1F and
2G). At these loci, tDHSs were present in T0, but not in N0, and
these sites were largely still maintained 3 weeks later in T0M.
The tDHSs were more likely to bind CA-RIT-NFAT and/or c-
MAF, but not TCF1. Furthermore, recently activated CD4 TB cells
generated by in vitro activation exhibit many of the same DHSs
as tolerant cells, and these regions are flanked by the active
chromatin modifications H3K27ac and H3K4me2 in TB cells (Fig-
ure 2G). It is likely that the tDHSs in tolerant cells will be similarly
embedded within extensive active chromatin domains that have
been formed during the tolerization process.Figure 3. DNase-Seq Analyses of In Vivo-Activated Naive and Tolerize
(A) DNase-seq tag density plots showing all peaks detected in replicate 1 of NAg
NAg. Alongside is the FC in mRNA level for the closest gene to the DHSs for TAg
(B and C) Average DHS signal at the 682 TAg-specific iDHSs (left) and at the 1,824
TAg (C).
(D) UCSC genome browser tracks showing DNase-seq and RNA-seq data from re
cells (NPI and TPI). DNase-seq, H3K27ac ChIP, and H3K4me2 ChIP tracks are sh
(E) Bar graph showing the percentage of iDHSs that are preferentially induced in
(F) UCSC genome browser tracks as for (D).
(G) Average DNase-seq signal for the 1,824 NAg-specific iDHSs and the 682 TAg-T0-Specific DHSs Are Proximal to T0- and TAg-Specific
Genes
Previously activated T cells maintain transcriptional memory by
employing pDHSs to establish active chromatin domains en-
compassing adjacent inducible regulatory elements (Figure 1B).
To assess the roles of the equivalent tDHSs in the regulation of
inducible gene expression in tolerant cells, we integrated the
mRNAdata for differentially expressed geneswith the differential
DHS peak data. Starting with the gene sets for mRNA values
greater than 50 defined in Figure S1B, we selected the annotated
genes that have been assigned to a specific genomic locus, and
further selected inducible genes on the basis that the TAg- and
NAg-specific genes are also 2-fold inducible compared with T0
and N0, respectively. This allowed us to define genes expressed
higher in T0 compared with N0 (460), N0 compared with T0 (80),
and inducible genes expressed higher in TAg compared with
NAg (138) and in NAg compared with TAg (226) (Table S5). We
then measured the distances from the transcription start sites
(TSSs) of differentially expressed genes to the closest of the
1,033 tDHSs (Figures 2H and 2I) and the closest of the 635 N0-
specific DHSs (Figures S2D and S2E). These analyses revealed
that the 1,033 tDHSs were preferentially located closer to the
TSSs of T0- and TAg-specific genes, with approximately 25%
of the TAg-specific genes located within 50 kb of a tDHS (Fig-
ure 2I). Hence these data suggest that tDHSs do indeed prime
closely linked inducible loci for rapid re-activation in cells re-
exposed to Ag. For example, tDHSs exist at the Il10, Ctla4,
and Tigit genes, which are more strongly induced in TAg than in
NAg (Figure 2G).
In contrast, priming seems to play little role in defining induc-
ible responses in naive cells, with only 10% of the 226 NAg-spe-
cific gene TSSs within 50 kb of N0-specific DHSs (Figure S2D).
Instead, the loss of DHSs in N0 correlates more closely with a
loss of expression in N0, whereby 25% of the 80 N0-specific
genes existed within 50 kb of N0-specific DHSs (Figure S2E).
An example of this is shown at the naive T cell-specific gene
Satb1 (Figure S2F), which has been implicated in repressing
Pdcd1 (PD-1) expression in T cells (Stephen et al., 2017).
Notably, the DHSs at Satb1 can bind TCF1, consistent with the
enrichment of LEF/TCF motifs at the 635 N0-specific sites.
Activation of Signaling Pathways Induces a Different
DHS Profile in Tolerant Cells
To investigate whether epigenetic priming at tDHSs supports
inducible chromatin remodeling in tolerant T cells, we performed
DNase-seq on NAg and TAg, and identified the differential DHSs
by ranking the regions based on the fold change of signald T Cells
and TAg ranked according to FC of sequence tag count for TAg compared with
compared with NAg.
NAg-specific iDHSs (right) for 0 compared with Ag (B) and NAg compared with
sting cells (N0 and T0), antigen-stimulated cells (NAg and TAg), and PI-stimulated
own for CD4 TB PI.
TAg or NAg that are found within 50 kb of the 1,033 tDHSs.
specific iDHSs in non-stimulated (N0 and T0) and PI-treated (NPI and TPI) cells.
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OPEN ACCESS(Figures 3A and S3A). We confirmed that the formation of TAg-
specific DHSs was generally correlated with increased gene
expression by measuring the difference in mRNA expression in
TAg compared with NAg for the genes that are adjacent to the cor-
responding DHSs (Figure 3A). To define high-confidence sub-
sets of specific DHSs, we intersected the peaks that were at
least 2-fold enriched in each sample for two independent pairs
of replicates. This gave 2,680 NAg-specific peaks and 1,959
TAg-specific peaks (Figure S3A). As we were specifically inter-
ested in iDHSs, we filtered them further to include only peaks
that were at least 3-fold higher in NAg compared with N0, or in
TAg compared with T0 (Figures S3B and S3C). This revealed
1,824 NAg-specific iDHSs and 682 TAg-specific iDHSs (Data
S1; Figure 3B), which were highly specific for just naive or
tolerant cells (Figure 3C). The same sets of specific DHSs were
also defined by a parallel analysis using DESeq2 and the same
fold change for each subset (p < 0.05), which identified 2,161
NAg-specific iDHSs and 923 TAg-specific iDHSs, including 88%
of the 1,824 NAg sites and 90% of the 682 sites TAg (Figure S3D).
Examples of TAg-specific iDHSs can be observed at the toler-
ance-associated Il10, Tigit, and Ctla4 loci (Figure 3D), where
iDHS induction correlated with increased mRNA gene expres-
sion in TAg cells. Furthermore, 19% of the TAg-specific iDHSs
were located within 50 kb of a tDHS (Figure 3E), consistent
with locus priming enabling more efficient activation of closely
linked enhancers residing in the same active chromatin domain
(Figure 1B). Many of the same iDHSs that are induced in TAg
are also induced in TB cells stimulated with PI (Figure 3D). In Fig-
ures 2G and 3D, it is also evident that regions associated with
iDHSs induced by PI in TB cells were already marked with
H3K4me2 and H3K27ac modifications before Ag stimulation.
In contrast with tolerant cells, naive T cells are not preferentially
primed by pDHSs at the NAg-specific genes in N0 cells, but
nevertheless still induce NAg-specific iDHSs (Figure 3F).NAg-Specific iDHSs Can Be Induced in Tolerant Cells by
Bypassing TCR/CD28 Signaling
The treatment of tolerant cells with PI enabled the induction of
many NAg-specific genes in tolerant cells, whereas the TAg-spe-
cific genes could not be induced by PI in naive cells (Figures 1E
and 1F). To determine whether this same trend was observed at
the chromatin level, we measured DNase I accessibility in naive
and tolerant cells treated with PI. ThemRNA induction correlated
closely with the changes in chromatin structure whereby TAg-
specific iDHSs could not be induced in naive cells, most likely
due to the lack of epigenetic priming, whereas NAg-specificFigure 4. Analyses of TF Interactions with DHSs in Naive and Tolerized
(A and B) Homer de novo identification of enriched TF motifs in the 1,824 NAg-sp
(C) Locations of transcription factor bindingmotifs (middle) at all DNase I peaks in t
for TAg compared with NAg (left). Aligned on the same axis are published ChIP-seq
et al., 2012) and constitutively active CA-RIT-NFAT and endogenous PI-induced
(D) Venn diagrams depicting the overlaps between the published data for 4,444
NFAT1 in PI-stimulated T cells (Martinez et al., 2015) with the 682 TAg-specific iD
(E) Average ChIP-seq signal for WT NFAT1 and CA-RIT-NFAT in PI-stimulated T
specific iDHSs (lower).
(F) HOMER de novo identification of inducible TF motifs within the 377 and 666 s
(G) Representative example of western blot assays of Fos, FosB, JunB, Jun, JuniDHSs were induced in tolerant cells treated with PI. This was
observed at both the local level (Figures 3D and 3F) and globally
at the 1,824 NAg and 682 TAg iDHSs (Figure 3G). The ability of PI
to overcome the block in tolerant cells is consistent with sup-
pression of TCR signaling upstream of PLC and PKC to inducible
TFs, a block that could be bypassed by direct activation of PKC
and RAS signaling by PI (Figure 1A).
NAg- and TAg-Specific iDHSs Are Governed by Distinct
Gene-Regulatory Networks
Tolerance involves the expression and activation of inhibitory re-
ceptors that antagonize TCR/CD28 signaling to the inducible
TFs, which create iDHSs. To identify gene-regulatory signatures
within the specific subsets of NAg and TAg DHSs, we performed
HOMER de novo motif analyses of enriched TF motifs (Figures
4A and 4B) and plotted the positions of the identified motifs
over the DHS coordinates, together with published ChIP-seq
data for these same TFs (Figure 4C). The NAg-specific iDHSs
had a complex TF motif signature reflecting the TCR/CD28-
inducible TFs AP-1, NFAT, NF-kB, and NR4A, but not EGR or
IRF family TFs (Figures 4A and 4C). The TAg-specific DHSs
were enriched for EGR and IRF motifs, but not motifs for the
TCR/CD28-induced TFs NF-kB and NR4A. The latter could be
explained in part by reduced expression for Nr4a3 and Nfkb1
in TAg compared with NAg (Figure 1E) and the absence of NAg-
specific iDHSs induced at these loci (Figure 3F). These analyses
were also confirmed using DESeq2, which identified essentially
the same subsets of NAg and TAg DHSs with the same motif
composition as those identified by the above pairwise analysis
(Figures S4A and S4B).
Evidence for Distinct AP-1, NFAT, and IRF Complexes in
TAg and NAg Cells
Although the TAg and NAg iDHSs both contained NFAT and AP-1
motifs, the TAg-specific iDHSs weremore enriched for NFATmo-
tifs, whereas the NAg iDHSs had a higher proportion of AP-1
binding motifs (Figures 4A–4C). Consistent with this, published
ChIP-seq data reveal higher levels of binding of the constitutively
active CA-RIT-NFAT (Martinez et al., 2015) at the TAg-specific
iDHSs and higher levels of JunB AP-1 binding at the NAg-specific
iDHSs in TB cells stimulated with PI (Bevington et al., 2016; Fig-
ure 4C). Because CA-RIT-NFAT has modifications that prevent
cooperative interactions with AP-1, these data may indicate
that much of the NFAT binding seen at TAg-specific DHSs is in-
dependent of AP-1, as seen in other models of exhaustion and
in TILs (Macia´n et al., 2002; Martinez et al., 2015; MognolT Cells
ecific iDHSs (A) and the 682 TAg-specific iDHSs (B).
he Ag-stimulated samples ordered according to the FC in sequence tag density
data for JunB in TB cells (Bevington et al., 2016), IRF4, BATF in CD4 T cells (Li
NFAT in CD8 T cells (Martinez et al., 2015) (right).
1 peaks detected in ChIP assays for CA-RIT-NFAT1 and/or endogenous (WT)
HSs (upper) or 1,824 NAg-specific iDHSs (lower).
cells at the 377 NFAT TAg-specific iDHSs (upper) and 666 NFAT-bound NAg-
ites.
D, and B2M proteins in T cells.
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OPEN ACCESSet al., 2017). In contrast, published ChIP-seq data for endoge-
nous NFAT1 (NFATc2) in CD8 T cells stimulated with PI, where
AP-1 will be efficiently induced (Martinez et al., 2015), revealed
NFAT binding to many NAg-specific iDHSs that are unable to
bind CA-RIT-NFAT (Figure 4C), suggesting direct cooperation
between NFAT and AP-1.
To investigate NFAT further, we identified all 44,441 ChIP
peaks that could bind either CA-RIT-NFAT1 or wild-type (WT)
NFAT1, and then intersected these with the 1,824 NAg and 682
TAg iDHSs (Figure 4D). This analysis revealed that 55% of the
682 TAg iDHSs (377 sites) were capable of binding at least one
form of NFAT, whereas just 36% of the NAg-specific iDHSs could
bind NFAT. The average level of binding of CA-RIT-NFAT1 de-
tected at the NAg iDHSs was also weaker than endogenous
NFAT1 binding (Figure 4E), again suggesting that cooperative
binding with AP-1 is more important at NAg iDHSs. This concept
was further supported by an enrichment of the composite NFAT/
AP-1 element detected by HOMER in the NAg, but not the TAg,
NFAT binding sites (Figure 4F). Examples of these patterns of
binding were observed at the TAg-specific genes Tigit and
Ctla4, where the TAg-specific iDHSs bind NFAT independently
of AP-1 (CA-RIT NFAT) (Figure S4C). In contrast, the NAg-specific
genes Fosl2 and Nfkb1 bind WT NFAT only when the cells are
stimulatedwith PI andAP-1 is present (WTNFATPI) (Figure S4D).
Furthermore, consensus motifs for cooperative NFAT/AP-1
binding were found at the NAg-specific genes, whereas the
TAg-specific iDHSs lacked the true composite element with
correctly spaced NFAT and AP-1 motifs (Chen et al., 1998).
The above observations and conclusions were supported by a
reduction in the total amount of the activating AP-1 proteins c-
Fos, Fosb, c-Jun, and JunB in TAg compared with NAg, whereas
levels of JunD were not reduced (Figure 4G). JunD has immuno-
suppressive functions in lymphocytes (Meixner et al., 2004), sug-
gesting that the ratio between JunD and other activating AP-1
proteins may influence the activity of AP-1 target genes in toler-
ized cells.
JunD has previously been detected in AP-1/IRF complexes in
T cells (Li et al., 2012). This is significant here because IRF family
proteins also play a role in anergy, in association with BATF/Jun
AP-1-like complexes, whereby these factors can bind to com-
posite IRF1/AP-1 motifs, including at the Il10 locus (Glasmacher
et al., 2012; Li et al., 2012). Although the composite IRF/AP-1
motif was not initially detected in the 682 TAg iDHSs (Figure 4B),
a direct search detected it in 12% of these sites, compared with
less than 3%of the 1,824 NAg iDHSs, and the IRF/AP-1motif was
identified by HOMER within the specific subset of 377 NFAT-
bound NAg iDHSs (Figure 4F). Furthermore, BATF has been iden-
tified in IRF/AP-1 complexes in anergic Tr1 cells (Karwacz et al.,Figure 5. Footprinting Analyses of TF Occupation in Naive and Toleriz
(A and B) Footprints within (A) NAg- and (B) TAg-specific iDHSs ordered accordin
(C and D) HOMER de novo identification of TF motifs enriched within footprints i
(E) Average profile showing the DNase I cuts around all NF-kB sites in the 1,824
(F and G) Examples of Wellington digital footprinting of DNase-seq data showing
DNase-seq data are shown for NAg and TAg, and ChIP-seq data for NF-kB (Oh e
(H) Average profile showing the DNase I cuts around all AP-1/IRF sites in the 1,82
(I) Examples of Wellington digital footprinting of DNase-seq data showing protecti
and TAg, and ChIP-seq data for NFAT1 (Martinez et al., 2015), IRF4, and BATF (L2017), and here we observed that published ChIP peaks for both
BATF and IRF4 are enriched in TAg, but not NAg, DHSs
(Figure 4C).
TF Occupancy Differs in Tolerant and Naive Cells
To look for further evidence of differential TF occupancy, we
generated higher read depth DNase-seq data for one sample
from each group and performed digital DNase I footprinting of
protected TF motifs. Using the Wellington footprinting algorithm
(Piper et al., 2013), we identified 1,490 protected sites in NAg-
specific iDHSs and 1,038 protected sites in TAg-specific iDHSs
(Figures 5A and 5B). Consistent with the results depicted in Fig-
ure 4, more AP-1 sites were occupied in NAg compared with TAg,
and more NFAT and EGR sites were protected in TAg compared
with NAg, while NF-kB and IRF sites were protected only in NAg
and TAg, respectively (Figures 5C and 5D). To further validate
these results, we plotted the forward and reverse DNase I cuts
surrounding all the NF-kB motifs that were present in the 1,824
NAg-iDHSs and 682 TAg-iDHSs (Figure 5E). NF-kB sites in the
1,824 iDHSs were more protected in the NAg sample, indicating
that this TF ismost likely bound here. Examples are shown in Fig-
ures 5F and S5A, where publically available ChIP-seq data (Oh
et al., 2017) show NF-kB binding correlating with these foot-
prints. Furthermore, in some cases where an NF-kB motif was
present within an iDHS that was induced in both NAg and TAg,
more efficient protection was observed in the NAg cells (Figures
5G and S5B). This further suggests a reduction in signaling to
NF-kB in tolerized cells.
We similarly investigated the occupancy of AP-1/IRF motifs
and determined that these composite motifs had a greater level
of protection in the 682 TAg-specific iDHSs than in the 1,824 NAg
iDHSs (Figure 5H). The TAg-specific genes Il10, Ikzf2, and Nrp1
loci each encompass strongly protected AP-1/IRF motifs (Fig-
ures 5I and S5C). Furthermore, ChIP-seq data from previously
published studies (Li et al., 2012) showed that these sites could
bind both IRF4 and BATF (Figures 5I and S5C). At the Il10 9 kb
and Nrp1 +177 kb DHSs, in addition to IRF4 and BATF binding,
NFAT peaks were identified in published ChIP data for CA-RIT-
NFAT, at sites where NFAT motifs were footprinted in TAg cells,
reinforcing the role of these three factors in gene-regulatory net-
works in tolerized T cells as has been shown in exhausted T cells
(Man et al., 2017).
TCR Signaling Complexes Are Disrupted in Tolerized T
Cells
To look for direct evidence of defective signaling in tolerant cells,
we used microscopy to investigate TCR signaling molecules
at the immune synapse formed after engagement ofed T Cells
g to the Wellington footprinting occupancy score.
n the 1,824 NAg-specific iDHSs (C) and the 682 TAg-specific iDHSs (D).
NAg-specific iDHSs in NAg (upper) and 682 TAg-specific iDHSs in TAg (lower).
protection of an NF-kB site at a NAg-specific iDHS (F) and at a shared iDHS (G).
t al., 2017).
4 NAg-specific iDHSs in NAg (upper) and 682 TAg-specific iDHSs in TAg (lower).
on of NFAT and composite AP-1/IRF motifs. DNase-seq data are shown for NAg
i et al., 2012).
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Figure 6. Altered Immunological Synapse Morphology and Reduced TCR-Proximal Signaling in Tolerant T Cells
T cells were tolerized by either intra-nasal (IN) delivery of peptides (A–E and G) or sub-cutaneous injection of peptides (F).
(A–C) Confocal microscopy of Th1-like cells or IN-tolerized T cells coupled with bone marrow APCs presenting cognate peptide for 10 min and imaged by
immunofluorescence confocal microscopy following immune-labeling for (A) CD28, (B) PKCq, or (C) Zap70.
(legend continued on next page)
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OPEN ACCESSantigen-presenting cells (APCs) with either in vitro-generated T
helper 1 (Th1) cells or T cells tolerized by repeated intra-nasal de-
livery of the 4Y peptide (Figure 6). We investigated the localiza-
tion of Zap70 and PKCq just downstream of TCR and PKC
signaling (Figure 1A). These analyses revealed that although
CD28 clustering at the TCR synapse occurs in both Th1 and to-
lerized T cells, Zap70 and PKCq can no longer be efficiently re-
cruited to the synapse in tolerized T cells (Figures 6A–6C). Quan-
titation of the proportion of signal at the synapse confirmed that
there was a global decrease in the amount of Zap70 and PKCq
that migrates to the synapse upon engaging APCs in tolerized
T cells compared with Th1 cells (Figure 6D). This breakdown of
signaling from the synapse correlated with a reduction of PKCq
T538 phosphorylation in tolerized cells (Figures 6E). We also as-
sessed the opposing roles played by PKCq and Cbl-b, which
functions as the gatekeeper of TCR/CD28 signaling (Li et al.,
2004; Qiao et al., 2013; Zhang et al., 2002; Figure 6F). Total inter-
nal reflection fluorescence (TIRF) microscopy revealed lower
levels of Zap70 and PKCq in the same plane as the TCR in toler-
ized T cells engaged with surface-bound CD3 Abs and higher
levels of Cbl-b, compared with Th1 cells (Figures S6A–S6D).
There was a negative correlation between PKCq and Cbl-b co-
localizing in activated T cells for Th1 and tolerized T cells (Fig-
ure 6G). Significantly, PKCq is just downstream of signaling
from CD28 and PI3K, and both PI3K and PKC are repressed
by Cbl-b (Figure 6F). PKCq is also a direct target of PMA, and
Ras proteins are indirect targets of PMA, thereby accounting
for the ability of PMA to overcome the block in signaling imposed
by CTLA4, PD-1, and Cbl-b (Figure 6F). Furthermore, a previous
study found that ubiquitination of the p85 subunit of PI3K by Cbl-
b blocks co-association of CD28 and the TCR, and thereby sup-
presses TCR signaling (Fang and Liu, 2001).DISCUSSION
A Two-Step Model Accounting for T Cell Tolerance
Increasing evidence shows that overactive immune responses in
allergy and autoimmunity can be corrected by Ag-specific immu-
notherapy. We established that cells exposed to soluble peptide
epitopes become anergic and switch from a pro-inflammatory
phenotype to an anti-inflammatory Tr1-like phenotype (Burkhart
et al., 1999; Sundstedt et al., 2003). These Foxp3ve T cells are
anergic and capable of suppressing other immune cells through
secretion of IL-10, which inhibits the Ag-presenting machinery of
APCs such as dendritic cells (Gabrysova´ et al., 2009). In the cur-
rent study, our genomic analyses utilized an in vivo model to
answer many of the outstanding questions about the epigenetic
mechanisms underlying and maintaining tolerance. Building
upon published data, we propose a comprehensive inter-con-
nectedmodel explaining T cell tolerance: (1) the increased activity(D) Quantification of confocal microscopy images showingmean enrichment of PK
from at least three biological replicates. p values were calculated by Mann-Whit
(E) Western blot analyses of PKCq T538 phosphorylation in Tg4 Th1 or IN-toleran
amounts of time.
(F) Model depicting TCR and CD28 signaling pathways that can be antagonized
(G) TIRF microscopy of Cbl-b and PKCq enrichment at the T cell immunological
Scale bars: 10 mM.of inducible inhibitory receptors lowers TCR/CD28 signaling
strength below the threshold required for induction of many im-
mune response genes; and (2) epigenetic reprograming of inhibi-
tory receptor genes allows them to be induced at a lower
threshold of TCR/CD28 signaling than that required for immune
response genes (Figure 7). Therefore, immune response genes,
such as Il2, Csf2, Tnf, Cd40lg, Nr4a3, and Ccl1, can be rapidly
induced in naive T cells and in effector T cells, but not in tolerized
T cells. The activation of TCR signaling in the absence of CD28 co-
stimulation also leads to loss of activation of Il2,Csf2, and Tnf (Yu-
kawa et al., 2020), consistent with suppression of CD28 signaling
in tolerized cells. Some of the immune response genes induced in
naive T cells, such as Nr4a3 (Figure 3F), are not epigenetically
primed, and thus require an elevated threshold of signaling for
their induction. Conversely, epigenetic priming creates an acces-
sible chromatin environment at immuno-suppressive genes such
as Ctla4 and Il10, meaning that they can still be induced in toler-
ized cells in the presence of reduced levels of TCR/CD28 signaling
(Figure 7). However, these genes are not yet primed in naive
T cells, meaning that their original epigenetic state was altered af-
ter the first round of activation by epigenetic priming at DHSs in
close proximity to inducible enhancers and promoters, allowing
more efficient induction as described by us previously for memory
T cells and TB cells (Bevington et al., 2016).Inhibitory Receptors Suppress TCR/CD28 Signaling in
Tolerized Cells
Wedemonstrated that tolerization leads to both high steady-state
levels and higher inducible levels of inhibitory receptors. The na-
ture of the suppressive pathways downstream of most inhibitory
receptors, including TIM3, LAG3, and TIGIT, still remains poorly
understood. However, it is known that both CTLA4 (Li et al.,
2004, 2019) and PD-1 (Fujiwara et al., 2017) mediate activation
of the repressive ubiquitin ligase Cbl-b, and our data suggest a
role for Cbl-b in limiting genomic responses in the tolerant state.
Cbl-b functions in setting the threshold of T cell activation and is
essential for both anergy (Tang et al., 2019; Zhang et al., 2002)
and the development of inducible regulatory T cells (Qiao et al.,
2013). In its absence, the response to TCR signaling is uncoupled
from co-receptor signaling, and mice develop spontaneous auto-
immunity (Bachmaier et al., 2000). In the anergic state associated
with tolerance and exhaustion, Cbl-b represses TCR/CD28
signaling by: (1) targeting the p85 subunit of PI3K for ubiquitination
and blocking its association with CD28 (Fang and Liu, 2001); (2)
directing ubiquitination of PKCq and targeting it for degradation
(Heissmeyer et al., 2004); and (3) directing the ubiquitination of
PLCg1, blocking its activation (Jeon et al., 2004; Figure 7).
Conversely, CD28 signaling promotes ubiquitination and degra-
dation ofCbl-b in effector T cells (Zhang et al., 2002). Furthermore,
effector T cells normally express Satb1, which represses Pdcd1Cq and Zap70 at the T cell-APC interface as in (B) and (C). Values were derived
ney test, error bars are SEM.
t T cells following activation with cross-linked anti-CD3/CD28 for the indicated
when Cbl-b is activated by CTLA4 or PD-1, or bypassed by PMA.
synapse in Th1-like cells or tolerized T cells.
Cell Reports 31, 107748, June 9, 2020 13
Figure 7. A Two-Step Model Accounting for T Cell Tolerance
In a normal T cell immune response, efficient co-activation of TCR and CD28 signaling leads to strong activation of inducible TFs and immune response genes. In
tolerized T cells, inhibitory receptors activate repressive factors, such as the ubiquitin ligase Cbl-b, which weaken but do not eliminate TCR/CD28 signaling. This
reduced level of signaling is sufficient to epigenetically prime and activate inhibitory receptor genes, but not most immune response genes.
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Pdcd1 activation in tolerized T cells occurs in parallel with repres-
sion of Satb1, and we confirmed that suppressive pathways
involving Cbl-b have been triggered in tolerized cells. Others
have also recently demonstrated that PD-1 engagement in
T cells leads to loss of expression of genes that rely on a high
threshold of signaling, such as Il2, Il3,Csf2,Ccl1, andCd40lg (Shi-
mizu et al., 2020). Consistent with these findings, we demonstrate
here that anergy in tolerized T cells involves amembrane-proximal
block in cell signaling because Zap70 andPKCq fail to localize effi-
ciently at the immunesynapse, thus failing to induceAP-1proteins
efficiently. Furthermore, we show that the block can be largely by-
passed using PMA to directly activate DAG-inducible pathways
downstream of PKCq and Ras (Figure 2F).
The Inducible Gene-Regulatory Network Is Rewired in
Tolerized T Cells
Our data establish that activation of repressive pathways during
tolerization leads to loss of both epigenetic priming and inducible
activation of many immune response genes. Our genome-wide
analyses demonstrate that the TCR/CD28-inducible gene-regu-
latory network is rewired compared with both naive T cells and14 Cell Reports 31, 107748, June 9, 2020normal effector T cells after tolerization. It is likely that much of
the epigenetic reprogramming described for TB and memory T
cells is either aborted or erased as part of the tolerization pro-
cess. Indeed, tolerized cells successfully prime only 3% of the
pDHSs defined by us previously in memory T cells.
The altered signaling network present in tolerized T cells acti-
vates different TF networks compared with the ones detected in
naive T cells in both resting and activated cells. Maf and Prdm1
levels were elevated in resting tolerant cells, and we observed
much higher inducible activation of Nfil3, Maf, and Prdm1 in
tolerant cells than in naive T cells. Maf expression correlates
directly with Il10 expression in tolerized cells (Burton et al.,
2014) and consistent with these findings, Gabrysova´ et al.
(2018) have shown that c-Maf controls IL-10 production in Th1,
Th2, and Th17 subsets. Here we show that induction of tolerance
involves the opening of chromatin at known c-Maf binding sites
(Figure 2), and that the tDHSs are enriched for AP-1motifs where
c-Maf is able to bind with other AP-1 proteins (Kataoka et al.,
1994). Furthermore, NFIL3, c-Maf, and Blimp1 are all likely to
be important drivers of anergy and immunosuppression because
theywere previously identified as regulators of Il10,Havcr2, Tigit,
and/or Pdcd1 expression in either T cells suppressed by IL-27
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OPEN ACCESS(Chihara et al., 2018; Zhu et al., 2015) or TILs derived from acute
myeloid leukemia patients (Zhu et al., 2017). These observations
were confirmed using regulatory T cells lacking Blimp1 (Cretney
et al., 2018). Overexpression of c-Maf is partially sufficient to
induce the exhausted T cell program, and Maf-deficient T cells
are more efficient at targeting tumors in vivo (Giordano et al.,
2015).
The gene-regulatory network that is activated in Ag-stimulated
tolerant cells has diverged from that detected in naive T cells or
TB cells. By integrating data identifying the TF motifs present
within the NAg- or TAg-specific iDHSs with protein expression
levels and foot-printing analyses, we have been able to infer a
model of how signaling to TFs is de-regulated during tolerization.
This includes: (1) a suppression of signaling to AP-1 and NF-kB,
(2) an increased utilization of NFAT in the absence of AP-1, and
(3) an increased occupancy of composite AP-1/IRF elements.
Indeed, increased binding of AP-1/IRF may occur through the
suppression of certain AP-1 family members. The AP-1/IRF
complex has been shown to contain BATF, JunD, and/or JunB,
but not c-Fos (Glasmacher et al., 2012; Li et al., 2012). Although
we observed a reduction in c-Fos, FosB, and JunB protein levels
in TAg cells, the level of JunD remained stable, which is of interest
here because JunD can function to suppress T cell responses
(Meixner et al., 2004). The data also imply redistribution of AP-
1 proteins away from conventional NFAT/AP-1 sites, which are
typically bound by Jun/Fos heterodimers (Chen et al., 1998)
and regulate immune response genes such as CSF2 (Johnson
et al., 2004), to AP-1/IRF sites found at immune-modulatory
genes, such as Il10 and Nrp1. By comparing our data with pub-
lished data, we found that TAg-specific DHSs were associated
with a gain of BATF and IRF4 binding and a loss of JunB, which
is consistent with our model. Furthermore, these same sets of
TFs have been implicated in rewiring gene-regulatory networks
in exhausted CD8 T cells ,where BATF, IRF4, and NFAT bound
at the same sites at the immuno-regulatory genes Lag3, Havcr2,
Tigit, Ctla4, and Pdcd1 (Man et al., 2017), and in Tr1 cells, where
IRF1 andBATF are key for preparing the chromatin landscape for
induction of the Tr1 gene program (Kro¨ger, 2017).
The Tolerized State Shares Features with Anergic and
Exhausted T Cells
Our previous genome-wide mRNA analyses (Burton et al., 2014)
and the data described here demonstrate that tolerized T cells
have moved away from the normal effector T cell program and
closer to that of the anergic state. For example, 43% of the
1,033 tDHSs identified here in tolerized CD4 cells were also re-
programmed in a chronic LCMV (lymphocytic choriomeningitis
virus) infection model of CD8 T cell exhaustion, including the
Ctla4 and Il10 loci, whereas most of the epigenetic priming
seen inmemory T cells is absent (Sen et al., 2016). Tolerized cells
resemble, but are not identical to, other anergic states, including
exhausted T cells produced during chronic infections, exhausted
TILs, T cells rendered anergic by unbalanced TCR/CD28
signaling, and in vitro-derived Tr1 cells (Figure S7). In each
case a concerted program of inhibitory receptor gene expres-
sion is activated, which typically includes Lag3, Havcr2 (TIM3),
Tigit, Ctla4, and Prdm1 (Blimp1) (Mognol et al., 2017; Singer
et al., 2016; Wherry and Kurachi, 2015), which oppose the func-tions of co-activators such as CD28 (Chen and Flies, 2013).
These anergic states also involve activation of a gene regulation
network driven byNFAT binding independently of AP-1 (Martinez
et al., 2015), and we find that certain AP-1 family proteins are
downregulated in tolerized cells.
We also observed some differences between our in vivo-
generated tolerant T cells and some other models of anergy.
Studies of exhausted T cells from TILs (Mognol et al., 2017)
and in vitro-derived tolerant T cells (Liu et al., 2019) found evi-
dence that TCR signaling to NR4A family TFs is maintained,
whereas we found that this pathway was suppressed in tolerized
T cells. We also observed a loss of LEF/TCF consensus binding
motifs in TAg DHSs, whereas TCF-1 plays an important role in
controlling the differentiation of precursors that give rise to ex-
hausted T cells during chronic infections (Chen et al., 2019). A
direct comparison ofmRNAdata described abovewith two inde-
pendent studies of anergic T cells suggests that tolerized cells,
Tr1 cells, and CD8+ve TILs all upregulate expression of TIM3,
LAG3, Blimp1, and NFIL3. However, tolerant and Tr1 cells pref-
erentially express Maf, IL-10, and IL-21, whereas tolerant T cells
and TILs preferentially express PD-1 (Figure S7).
The sum of these studies reveals that different anergic and reg-
ulatory T cell states do indeed share the common utilization of im-
muno-suppressive factors by virtue of preferential epigenetic
priming of their genes, thereby rendering them more responsive.
The deficiency of the immune response is a direct consequence
of inhibitory receptors blocking induction ofmost inducible genes.
These studies also give encouragement for the expanded use of
Ag-inducible tolerization as a strategy for combatting auto-im-
mune disorders, and give clues as to how immune responses
might be boosted in cancer and chronic infections. Significantly,
this is no longer a distant goal, because peptide therapy is already
being tested in auto-immune diseases. Our recent phase 1 and 2
clinical trials show that the MBP peptide tolerization strategy
described above is giving positive results as a therapy for multiple
sclerosis (Chataway et al., 2018), and a similar protocol using
thyrotropin receptor peptides has delivered improvements in pa-
tients with Graves’ hyperthyroidism (Pearce et al., 2019). The cur-
rent study has now provided a comprehensive understanding of
the molecular basis of this therapeutic approach, which may
one day become common practice.STAR+METHODS
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NEBNext oligonucleotides NEB Cat# E7335S
NextSeq High Output kit v2.5 150 cycles Illumina Cat# 20024907
NextSeq 500/550 High Output kit v2 75
cycles
llumina Cat# FC 404-2005
Kapa Hyper-Prep kit Kapa Biosystems Cat# KK8500
Kapa Library Quantification Kit Kapa Biosystems Cat# KK4824
MinElute Gel Extraction Kit QIAGEN Cat# 2860
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
Deposited Data
Raw and analyzed data This paper GEO: GSE147268
TCF1 ChIP - thymocytes (Dose et al., 2014) GEO: GSE46662
c-MAF ChIP-seq - Th17 cells (Ciofani et al., 2012) GEO: GSM1004799
NFAT-CA-RIT-NFAT1, mock NFAT1, NFAT-
CA-RIT-NFAT1 PI, mock NFAT1 PI in CD8
T cells
(Martinez et al., 2015) GEO: GSM1570758
IRF4 ChIP-seq in CD4 T cells and BATF in
CD4 +IL-21 T cells
(Li et al., 2012) GEO: GSE39756
JUNB ChIP-seq in CD4 TB PI cells,
H3K4me2 and H3K27ac ChIP-seq in CD4
TB and TB PI cells, and DNase I in CD4 TB
and CD4 TB PI
(Bevington et al., 2016) GEO: GSE67443
p65 ChIP-seq in Tconv cells stimulated with
CD3/CD28
(Oh et al., 2017) GEO: GSE99319
Experimental Models: Organisms/Strains
Mouse: Tg4-H2u (Liu et al., 1995) https://pubmed.ncbi.nlm.nih.gov/7584132
Mouse: B10.PLmice (B10.PL-H2u H2-T18a/
(73NS) SnJ
Jackson Laboratory
Oligonucleotides
Oligonucletide primers are listed in Table S6 N/A
Software and Algorithms
TopHat (version 2.1.1) (Kim et al., 2013) https://ccb.jhu.edu/software/tophat/index.
shtml
HTSeq-count (version 0.9.1) (Anders et al., 2015) https://pypi.org/project/HTSeq/
DESeq2 (version 1.18) (Love et al., 2014) https://bioconductor.org/packages/
release/bioc/html/DESeq2.html
EdgeR (version 3.24) (Robinson et al., 2010) https://bioconductor.org/packages/
release/bioc/html/edgeR.html
R (version 3.4.3) The R project for Statistical Computing https://www.r-project.org/
Bowtie2 v2.2.3 (Langmead and Salzberg, 2012) http://bowtie-bio.sourceforge.net/bowtie2/
index.shtml
MACs version 1.4.2 (Zhang et al., 2008) https://github.com/taoliu/MACS
MACS2 callpeak (Galaxy Version 2.1.1) (Zhang et al., 2008) https://usegalaxy.org/
HOMER v4.9.1 (Heinz et al., 2010) http://homer.ucsd.edu/homer/index.html
Java Treeview v1.1 (Saldanha, 2004) https://sourceforge.net/projects/jtreeview/
Bedtools (Galaxy Version 2.26.0.0) (Quinlan and Hall, 2010) . https://bedtools.readthedocs.io/en/latest/
Trimmomatic v0.32 (Bolger et al., 2014) http://www.usadellab.org/cms/index.php?
page=trimmomatic
Wellington Method - pyDNase 0.2.4 (Piper et al., 2013) https://pythonhosted.org/pyDNase/
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Lead Contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact Peter
Cockerill (p.n.cockerill@bham.ac.uk).
Material Availability
This study did not generate any unique reagents.e2 Cell Reports 31, 107748, June 9, 2020
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OPEN ACCESSData and Code Availability
The accession number for the data reported in this paper is GEO: GSE147268. The article also includes previously published data-
sets: TCF1 ChIP-Seq in thymocytes – GSE46662 (Dose et al., 2014), c-MAF ChIP-seq in Th17 cells - GEO: GSM1004799 (Ciofani
et al., 2012), NFAT-CA-RIT-NFAT1, WT NFAT1, NFAT-CA-RIT-NFAT1 PI, WTNFAT1 PI in CD8 T cells - GEO: GSM1570758 (Martinez
et al., 2015). IRF4 ChIP-seq in CD4 T cells and BATF in CD4 +IL-21 T cells GEO: GSE39756 (Li et al., 2012), JUNBChIP-seq in CD4 TB
PI cells, H3K4me2 and H3K27ac ChIP-seq in CD4 TB and TB PI cells, and DNase I in CD4 TB and CD4 TB PI, GEO: GSE67443 (Bev-
ington et al., 2016) and p65 ChIP-seq in Tconv cells stimulated with CD3/CD28 - GEO: GSE99319 (Oh et al., 2017).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Tg4 transgenic Mice
Tg4-H2u mice expressing the ab TCR (Va4, Vb8.2) of the MBP Ac1-9-specific hybridoma 1934.4, derived from an encephalitogenic
T cell clone have been described previously (Liu et al., 1995). Tg4 mice have a skewed CD4+ T cell repertoire where over 90% of the
CD4+ T cells are Vb8+. Male and female mice aged between 6-12 weeks were used. Animals were housed under specific pathogen-
free conditions, and experiments were performed in accordance with the UK Home Office Project License held by D.C.W. and
approved by the University of Birmingham ethical review committee. T cells from the peripheral blood of Tg4 mice were phenotyped
for CD4 and Vb8 by flow cytometry.
Cells
Th1 effector cells were generated in vitro by culturing splenocytes, from which red blood cells were depleted, from Tg4 mice with
10 mg/ml MBP Ac1-9 [4K] and 5 ng/ml rmIL-12 (Peprotech) for 72 hours in complete RPMI. Cells were further expanded for 6-
8 days in complete RPMI supplemented with 20 U/ml rhIL-2 (R&D) (Hill et al., 2013). Splenocytes from tolerized mice were also
expanded in vitro before analysis by culturing for 5 days in complete RPMI with 10 mg/ml MBP Ac1-9 [4K] and 20 U/ml rhIL-2 (An-
derson et al., 2005). Bone marrow-derived dendritic cells were generated from B10.PL mice (B10.PL-H2u H2-T18a/(73NS) SnJ orig-
inally from the Jackson Laboratory) by culturing the non-adherent fraction of disaggregated bone marrow with 10 ng/ml rmGM-CSF
(Miltenyi Biotec) in complete RPMI for 10-12 days (Inaba et al., 1992). BM-DC were routinely > 85% MHC-II+ as measured by flow
cytometry.
METHOD DETAILS
Induction of tolerance by sub-cutaneous injection of peptides
For most of the tolerized T cell experiments described here (T0 and TAg), tolerance was induced by administering 200 mL doses of the
MBP Ac1-9[4Y] subcutaneously in the flank of un-anaesthetized mice every 3-4 days for 7 doses. The amount of peptide was
increased until the maximum dose was reached and maintained, as defined in Figure 1C (0.08 mg, 0.8 mg, 8 mg, 80 mg peptide/
0.2ml PBS). For N0, 200 mL of PBS was administered in the same dosing strategy. 2 hours prior to sacrifice a final dose of 200 mL
of PBS (N0 and T0) or 200 mL of 400 mg/ml MBP Ac1-9 [4Y] (NAg and TAg) was given. For T0M, mice were sacrificed 3 weeks after
the final dose.
Induction of tolerance by intra-nasal peptides
In Figures 6A–6G and S6, Tg4 mice were tolerized by intranasal administration of 10 doses of 80 mg MBP Ac1-9 [4Y]) at 3-4 day in-
tervals (Gabrysova´ et al., 2009; Sundstedt et al., 2003).
CD4+ T cell Selection
For most experiments CD4+ T cells were purified using the MagniSort Mouse CD4 T cell Enrichment Kit (8804-6821-74) according to
the manufacturer’s instructions. For the western blotting in Figure 6E and microscopy experiments Figures 6 and S6, CD4+ T cells
were purified by magnetic separation (Miltenyi Isolation Kit II) according to the manufacturer’s instruction.
In vitro activation of T cells
For western blot analyses, CD4+ T cells were activated by incubating with 10 mg/ml biotinylated anti-CD3ε (clone 145-2C11, BD) and
10 mg/ml biotinylated anti-CD28 (clone 37.51, BD) for 30 minutes followed by crosslinking with 10 mg/ml streptavidin (Jackson Im-
munoresearch) at 37C for the indicated times. For mRNA and DNase-Seq analyses, CD4+ T cells were re-suspended in complete
RPMI with 20 ng/ml phorbol myristate acetate (PMA) and 2 mM Calcium Ionophore A23187 (CaI) (NPI and TPI). For the mRNA time
course cells were harvested at 30’, 60’, 120’, 240’ and 480’. For DNase-Seq and RNA-seq experiments cell were harvested at 120’.
Western blot analyses of protein expression
Proteins were extracted in 50 mM Tris, 120 mMNaCl, 1 mM EDTA with 1% IGEPAL CA-630 and protease and phosphatase inhibitor
cocktails (Thermo) before SDS-PAGE and western blotting. The antibodies used in this study were anti-PKCq clone 27/PKCq
(BD Bioscience), anti-PKCq pT538 ployclonal (Cell Signaling Technologies #9377) , anti-c-Jun Rabbit monoclonal (Cell SignalingCell Reports 31, 107748, June 9, 2020 e3
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OPEN ACCESSTechnologies #9165), anti-c-fos Rabbit monoclonal (Cell Signaling Technologies #2250), anti-fosB Rabbit monoclonal (Cell Signaling
Technologies #2251), anti-JunB Rabbit polyclonal (Santa Cruz Biotehnology #sc-46X) anti-JunD Rabbit polyclonal (Santa Cruz Bio-
tehnology #sc-74X) and anti-beta-2-microglobulin (Abcam #AB75853).
Microscopy sample preparation
Before imaging, BM-DC were incubated with 1 mg/ml LPS (Sigma) for 16-18 hours, washed and then incubated for 2 hours with 1 mg/
ml MBP Ac1-9[4Y]. DC-T cell couples for confocal microscopy were prepared by combining activated and peptide-loaded BM-DC
andmagnetically enriched CD4+ T cell at a ratio of 1:2 at 3x106 cells/ml. Coupling was synchronized by brief centrifugation (75 g) in a
round bottom plate and the cells were allowed to interact for 5minutes at 37Cbefore the cells were gently transferred to pre-warmed
glass slides and incubated for a further 5 minutes. Cells were fixed in 4% buffered PFA before immune-labeling. For TIRF-M imaging,
glass coverslips (Mat-Tek II) were pre-coated with 2 mg/ml anti-CD3ε clone 145-2C11, BD) and 1 mg/ml anti-CD28 (clone 37.51, BD).
CD4+ T cells were allowed to interact with the antibody coated surface for 8 minutes at 37C before fixation and immune-labeling.
Primary antibodies used were anti-PKCq clone 27/PKCq (BD Bioscience) at 2.5 mg/ml, anti-Zap70 clone D1C10E (Cell Signaling
Technologies) at 2.5 mg/ml, anti-CD28 clone PV.1 (Abcam) at 1 mg/ml and anti-Cbl-b polyclonal H121 (Santa Cruz - discontinued)
at 5 mg/ml. Secondary antibodies, goat anti-rabbit IgG-DyLight488, donkey anti-mouse IgG-Cy3 and goat anti-Armenian hamster-
Cy2. (Jackson Immunoresearch) were used at 2.5 mg/ml.
Microscopy
Confocal laser scanning microscopy was performed on a DMI 6000 inverted epifluorescence microscope equipped with an
SP5-AOBS confocal scanning system (Leica Microsystems). Total internal reflection fluorescence microscopy (TIRF-M) was
performed on a DMI 6000 inverted epifluorescence microscope attached to an AM TIRF MC system (Leica). An estimated pene-
tration depth of 100 nm was used. Multi-color imaging was performed using sequential laser scanning. Conjugates between
APC and T cells were identified using the bright field channel without reference to fluorescence channels and laser power,
gain, offset and averaging/additive functions were kept constant between samples which were to be compared. Image analysis
was performed with Volocity 5 (Perkin Elmer). Analysis of synaptic protein enrichment in DC-T cell couples were performed by
measuring the fluorescence intensity of the T cell membrane-proximal region at areas of the interface and distal from the inter-
face. The enrichment of a protein at the interface was represented as the ratio if these values. In TIRF-M experiments, protein
accumulation at the interface was assessed by measuring the relative fluorescence intensity within the cell footprint, defined by
bright field images. Where indicated, the ratio of two fluorescence channels is presented in pseudo color using the ‘Ratio’ tool in
Volocity 5.
mRNA isolation and quantitative PCR
Total RNA was isolated using PicoPure RNA Isolation Kit (KIT0204) according to the manufacturer’s instructions. RNA was
reverse transcribed using Superscript IV reverse transcriptase (Thermo Fisher) according to the manufacturer’s protocol.
qPCR was carried out using Applied Biosystems SYBR green master mix (Thermo Fisher). Primers used for qPCR are listed
in Table S6.
RNA-seq library preparation
Ribosomal RNA was depleted using NEBNext rRNA depletion kit (E6310L) according to the manufacturer’s instructions. RNA-seq
libraries were prepared from 30 ng RNA using the NEBNext Ultra II kit (E7760S) using the NEBNext oligonucleotides (E7335S) ac-
cording to the manufacturer’s instructions. Samples were sequenced using the NextSeq High Output kit v2.5 150 cycles (Illumina,
20024907).
DNase I hypersensitive site analysis
DNase I digestions were carried out as described previously (Bevington et al., 2016). In brief, cells were re-suspended at
1x107 cells/ml in DNase I buffer (60 mM KCl, 15 mM NaCl, 5 mM MgCl2, 100 mM Tris-HCl pH 7.4, 1 mM EGTA pH 7.4,
0.3 M sucrose, 0.2% NP40, 1 mM CaCl2 and DNase I). 1x10
6 cells were digested for 30 at 22C before the reaction was termi-
nated by the addition of SDS (final concentration 0.5%). Samples were treated with 0.5 mg/ml Proteinase K at 37C overnight
followed by 0.2 mg/ml RNase A for 1 hour. DNA was purified by phenol/chloroform extraction and fragments were separated
by agarose gel electrophoresis. Small DNA fragments (50-250 bp) were extracted and purified (QIAGEN Minelute Gel extraction
Kit) before library preparation.
Library preparation
DNase I libraries were prepared using the Kapa Hyper-Prep kit (KAPA Biosystems) according the manufacturer’s instructions.
Libraries were amplified by PCR and fragments of 200-300bp were gel purified (QIAGEN Minelute Gel extraction Kit) before qPCR
validation and quantification (KAPA Library Quantification Complete kit -ABI Prism). Samples were pooled and sequenced using
the NextSeq 500/550 High Output kit v2 75 cycles (Illumina, FC 404-2005).e4 Cell Reports 31, 107748, June 9, 2020
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RNA-seq Analysis
Paired-end reads were aligned to the mouse genome (version mm9, build 37) using TopHat (version 2.1.1) (Kim et al., 2013; Kim and
Salzberg, 2011; Langmead et al., 2009; Trapnell et al., 2009). Transcript counts were calculated with HTSeq-count (version 0.9.1)
(Anders et al., 2015) using gene models from Ensembl as reference. Differential gene expression analysis was carried out using
the DESeq2 (version 1.18) (Love et al., 2014) and EdgeR (version 3.24) (McCarthy et al., 2012; Robinson et al., 2010) packages in
R (version 3.4.3). Only genes that could be reproducibly identified as statistically significant by both DESeq2 (FDR < 0.05) and EdgeR
(p < 0.05) were retained for further analysis. This was done to reduce the number of false positive results and ensure that the gene sets
used in downstream analyses were robust. Genes that had a fold-change of at least 2 (as calculated by DESeq2) were deemed to be
differentially expressed. PCA and heatmap plots were generated using ggplot in R.
Definition of gene expression groups
The 460 T0 and 80 N0 specific gene mRNAs were defined as 2-fold upregulated between T0 and N0 and N0 and T0 respectively with a
minimum read count of 50. The 138 TAg and 226 NAg specific genes were defined as 2 fold upregulated between TAg and NAg and NAg
and TAg respectively with a minimum read count and 50. In addition these genes were filtered to only include genes which were 2 fold
upregulated when T0 or N0 were stimulated with Ag.
DNase-Seq - alignment, coverage and peak detection
Raw sequencing reads were aligned to mm9 using bowtie2 (Galaxy Version 2.3.2.2) (Langmead and Salzberg, 2012) with the preset
–very-sensitive-local. Coverage files were generated using MACs version 1.4.2 using –g mm –keep-dup auto –w -S as parameters
(Zhang et al., 2008).
Normalization of DNase-Seq datasets
The BAM files from the duplicate samples of N0, T0, NAg and TAg weremerged using BamTools (Galaxy Version 0.0.2). Amaster set of
peaks were determined using MACS2 callpeak (Galaxy Version 2.1.1). 69743 summits were identified across all samples. The
sequence tags ± 200bp from the peak summit were counted for the 69743 peaks for each individual sample using the annotatePeaks
function of the HOMER package (Heinz et al., 2010). The samples were normalized using a correction factor based on the median of
the top 25,000 peaks for each sample. Correction factors were then used to normalize genome browser scales, average sequence
tag density plots and contrast levels in heatmaps.
Unions of DNase-Seq data
For each sample the sequence tags were counted ± 200bp for the 69743 peaks and the significant peaks were determined using a
cut off which excluded background and insignificant peaks. Two samples were compared by merging the peaks using the sort and
merge function of the bedtools package (Quinlan and Hall, 2010)to give a union which included common and unique peaks. For the
unions between T0 and N0 peaks were further filtered to eliminate sine elements. The sequence tags were counted ± 200bp from the
summits of the peaks in the union, normalized using the correction factor and the fold change difference was calculated between the
2 samples. The data were visualized as sequence tag density profiles ordered according to the fold change difference in sequence
tag density of one sample compared to the other.
Sequence tag density profiles
Sequence tag density profiles were generated using the annotatePeaks function of the HOMER package using -hist 10 -ghist -size
2000 as parameters. Images were generated using Java Treeview v1.1 (Saldanha, 2004).
Average sequence tag density plots
Average sequence tag density plots ± 1 kb around the DHS summit were generated using the annotatePeaks function of the HOMER
package using -hist 10 -size 2000 as parameters.
Differential peak analysis using DESeq2
Only peaks which were present in both samples for each condition were used in analyses. Reads were counted using featurecounts
and DESeq2 (Galaxy version 2.11.40.6) was used to determine differential peaks between 2 conditions. Only regions with p < 0.05
were included.
RNA fold change heatmaps
Peaks were assigned to the closest gene within 100 kb of the transcription start site (TSS) using the annotatePeaks.pl function in
Homer v4.9.1 (Heinz et al., 2010). The fold-change values for these genes were then plotted as a heatmap using Java TreeView
v1.1 (Saldanha, 2004).Cell Reports 31, 107748, June 9, 2020 e5
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The distance between the DHSs and the TSSs of upregulated genes was calculated using the BEDTools closestBed function (Galaxy
Version 2.26.0.0). Genes were grouped according to distance from the DHSs to the TSSs of the genes in intervals.
Motif discovery
De novo motif analysis was performed using the findMotifsGenome.pl function of the HOMER package. Motifs were identified ±
100 bp from the peak summit.
Footprinting analysis
Raw sequencing data from high-depth DNase-Seq experiments were processed to remove low-quality reads and sequencing adap-
tors with Trimmomatic v0.32 (Bolger et al., 2014). The processed reads were then aligned to the mouse genome (version mm9) with
Bowtie2 v2.2.3 (Langmead and Salzberg, 2012) using the option–very-sensitive-local. Footprints were identified using theWellington
method implemented in pyDNase 0.2.4 (Piper et al., 2013). DNase I cut profiles were calculated using the in-built functions in
pyDNase.e6 Cell Reports 31, 107748, June 9, 2020
